Neuroleptic malignant syndrome following levomepromazine discontinuation

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 22, Issue 2, 2010, Pages

  Tanii, Hisashi ^a   Saka, Keiichi ^b   Inoue, Ken ^c   Okada, Motohiro ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hinaga General Hospital for Mental Care   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CREATINE KINASE; DANTROLENE; LEVOMEPROMAZINE; VALPROIC ACID;

ANOREXIA; COMMON COLD; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; FEVER; GAIT DISORDER; HUMAN; INFECTION; INSOMNIA; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; LABORATORY TEST; LETTER; LEUKOCYTE COUNT; MENTAL DEFICIENCY; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; PERSECUTORY DELUSION; PRIORITY JOURNAL; PULSE RATE; RESTLESSNESS; WITHDRAWAL SYNDROME;

EID: 77952408525     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2010.22.2.247.e16     Document Type: Letter

References (3)

1. Tadke RR, Suryavanshi P: Use of intravenous valproate in a patient with neuroleptic malignant syndrome. J Neuropsychiatry Clin Neurosci 2006; 18:131-132 (Pubitemid 43277271)
2. Margetic B, Aukst-Margetic B: Neuroleptic malignant syndrome and clozapine withdrawal at the same time? Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:145-147
3. Viejo LF, Morales V, Punal P, et al: Risk factors in neuroleptic malignant syndrome: a case-control study. Acta Psychiatr Scand 2003; 107:45-49 (Pubitemid 36092243)